CELL BEHAVIOR TARGETED MEDICINES Trademark

Trademark Overview


On Wednesday, October 7, 2020, a trademark application was filed for CELL BEHAVIOR TARGETED MEDICINES with the United States Patent and Trademark Office. The USPTO has given the CELL BEHAVIOR TARGETED MEDICINES trademark a serial number of 90239573. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 23, 2022. This trademark is owned by Cellarity, Inc.. The CELL BEHAVIOR TARGETED MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and therapeutic products for the treatment of hematological diseases and disorders, cancer, immunological diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders, and respiratory diseases and disorders

Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis, namely, drug discovery and development; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, ef...
cell behavior targeted medicines

General Information


Serial Number90239573
Word MarkCELL BEHAVIOR TARGETED MEDICINES
Filing DateWednesday, October 7, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, March 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and therapeutic products for the treatment of hematological diseases and disorders, cancer, immunological diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders, and respiratory diseases and disorders
Goods and ServicesProviding on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis, namely, drug discovery and development; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 20, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellarity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events


Event DateEvent Description
Wednesday, March 23, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, March 23, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, March 23, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 31, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 31, 2021FINAL REFUSAL E-MAILED
Tuesday, August 31, 2021FINAL REFUSAL WRITTEN
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 2, 2021NON-FINAL ACTION E-MAILED
Tuesday, February 2, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 26, 2021ASSIGNED TO EXAMINER
Friday, November 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM